Pentwater Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History

Pentwater Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.59 - $15.86 $1.75 Million - $4.2 Million	-265,000 Reduced 72.6%	100,000 $765,000
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $250,799 - $546,700	-55,000 Reduced 13.1%	365,000 $2.73 Million
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $128,400 - $192,800	20,000 Added 5.0%	420,000 $2.8 Million
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $716,000 - $1.27 Million	100,000 Added 33.33%	400,000 $3.08 Million
Q1 2022 May 16, 2022	BUY	$6.16 - $18.03 $123,200 - $360,600	20,000 Added 7.14%	300,000 $2.15 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $242,100 - $327,900	15,000 Added 5.66%	280,000 $4.8 Million
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $237,875 - $516,625	12,500 Added 4.95%	265,000 $6.1 Million
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $4.55 Million - $9.45 Million	252,500 New	252,500 $9.22 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.